Latest News about FLHLF

Recent news which mentions FLHLF

< Previous 1 2 Next >

Supply Partnerships: Filament's Psilocybin Trial In Canada, PharmAla's MDMA Program In Australia

February 14, 2023

EXCLUSIVE: Defining 'Natural' Psychedelics, State Regulations & Ayahuasca's Benefits

January 26, 2023

Psyched: States With Psychedelics Legalization Bills, Next-Gen Molecule For Addiction Treatment And More

January 25, 2023

Psychiatry And Business Collaborate: European Psychedelics Trial Tackles Alcohol Addiction

January 20, 2023

6 Psychedelics Companies Take Action: Here Are The Latest, Major Announcements

January 10, 2023

Psyched: First Ayahuasca Pill Created, Psychedelics Legalization Predicted, UK's Research Support And More

December 19, 2022

EXCLUSIVE: The Psychedelics Debate Is 'Raging' As Filament Debuts Ayahuasca Pill

December 16, 2022

Psychedelics Company Filament Signs Licensing Deal With Psyence In US, UK And EU

December 15, 2022

EXCLUSIVE: Ayahuasca Pill Is Officially Here, Filament CEO Discusses Future Plans

December 15, 2022

Psyched: Fed Guidelines And Research Production Quotas, Protests In Canada, Cal's Decrim Project

December 06, 2022

Natural Psychedelics Extraction & Standardization Obtains Two New US Patents

December 01, 2022

Psyched: Colorado Legalizes Psychedelics, NYC Treats Alcoholism With Ketamine, $30M Series A For Startup

November 15, 2022

Filament Health Shares Q3 2022 Results, On Road To Becoming Industry's Natural Psilocybin Supplier

November 11, 2022

Psyched: Brock Pierce Joins Psychedelic VC, Colorado's Psychedelics Legalization, Zappy Zapolin's Open Letter & More

November 07, 2022

EXCLUSIVE: Crypto Billionaire Brock Pierce Joins Psychedelic Venture Fund, Says 'Potential Reward Is Immeasurable'

November 04, 2022

Filament Begins First Ever FDA-Approved Clinical Trial On Naturally-Derived Psychedelic Drugs

July 08, 2022

Canadian Special Access Program Further Authorizes Novel Psychedelic Drugs For Emergency Treatments

June 16, 2022

Psyched: Elon Musk Tweets About Psychedelics, Numinus Acquires Novamind, Colorado Gov. Signs MDMA Legalization Bill

June 15, 2022

Two Psychedelics Drug Development Companies Work To Produce Novel Plant-Based Compounds For Mental Health Disorders

June 09, 2022

Optimi Health Signs Two New Supply Agreements In Less Than a Week

May 31, 2022

Patents In The Psychedelics Space: Good Or Bad? It's Complicated, Here's What The Experts Say

May 20, 2022

Filament Health Keeps Adding Patents To Its Portfolio, Just Received Its Fourth

April 27, 2022

Psyched: Big Pharma's Sanofi Enters Psychedelics Space, DNA From 80 Psilocybe Mushrooms Published Online, Maine Psychedelics Bill Shelved

April 25, 2022

Filament Health Talks Psilocybins, Psilocins And How Natural Psychedelics Could Conquer The Market

April 22, 2022

Psyence, Filament Strike Magic Mushroom Product Licensing Agreement: What You Need To Know

April 19, 2022

Filament Health Acquires Patent For Extracting And Standardizing Natural Psilocybin

April 13, 2022

Psyched: Psychedelics ETF Launches On NYSE, Psilocybin Trial Approved For Depression, DMT Study Begins

February 07, 2022

Magic Mushrooms For Depression: Clinical Trial Of Active Compound Approved For Patients Using Antidepressants

January 31, 2022

Psychedelic Stock Gainers And Losers From January 17, 2022

January 17, 2022

Psyched: Canada's Access To Psychedelic Medicines, Psilocybin No Cognitive Side Effects, Psilocybin Bill Washington

January 10, 2022

< Previous 1 2 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.